NFH
HZNP

NEXT Financial Holdings’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

NEXT Financial Holdings’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$85K Buy
+3,210
New +$76.1K 0.02% 584

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NEXT Financial Holdings's HZNP Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2019: 3,210 shares worth $85K. The stake represents 0.02% of the portfolio and ranks #584 among its holdings.

297 funds tracked by Wall St. Rank hold HZNP as of Q1 2019.

  • NEXT Financial Holdings held 3,210 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $85K as of Q1 2019.
  • Horizon Therapeutics Public Limited Company Ordinary Shares was a new NEXT Financial Holdings position in Q1 2019.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.02% of NEXT Financial Holdings's portfolio in Q1 2019, its #584 holding.
  • 297 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.